CervoMed’s therapy demonstrates significant improvement in patients

Oxford Medical Products targets overweight individuals

FSCD therapy meets all endpoints in interim analysis

Scottish Medicines Consortium approves new option for mCRPC patients

NICE convenes third committee meeting for additional appraisal consideration

Octapharma supports NHS in building resilient supply chain

Cohort expansion phase commences with promising results

Innovative digital transformation leads to significant improvements

Lead candidate for lung infections moves to human trials

New research highlights NHS approval gap compared to other cancers